MSLE CIK: 1421642

Satellos Bioscience Inc.

  • Canada
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY23
FY24
FY25
FY23 – FY25

Assets

(positive)
Change from FY23 to FY25
millions USD
FY23:
30.5
FY24:
50.7
FY25:
31.9
(positive)
Change from FY23 to FY25
millions USD
FY23:
3.01
FY24:
0.00
FY25:
0.01
Total assets
Change from FY23 to FY25
millions USD
FY23:
33.5
FY24:
50.7
FY25:
31.9

Liabilities & Equity

(negative)
Change from FY23 to FY25
millions USD
FY23:
2.73
FY24:
3.58
FY25:
4.11
(negative)
millions USD
FY23:
0
FY24:
0
FY25:
0
(positive)
Change from FY23 to FY25
millions USD
FY23:
30.8
FY24:
47.2
FY25:
27.8
Total liabilities & equity
Change from FY23 to FY25
millions USD
FY23:
33.5
FY24:
50.7
FY25:
31.9

All amounts in millions USD Data source:SEC EDGAR